CANDESARTAN CILEXETIL | A078702 | MYLAN PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Attachment 3 - Candesartan Cilexetil PI - HIGHLIGHTS OF PRESCRIBING INFORMATI... FDA-2021-P-0510 Hyman, Phelps & McNamara, P.C. filed a suitability petition regarding candesartan cilexetil, requesting FDA consideration of the drug's suitability for approval under the abbreviated new drug application pathway. The petition references proposed prescribing information highlights for the angiotensin | Suitability | 2021-05-26 | Open | Hyman |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.